CIK 0001710072
- Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821725586
- Phone
- +1 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 4 Grant or award Director acquired 559 shares (grant or award)
- 4 Planned sale Chief Scientific Officer sold 200 shares at $30.02 ($6,004)
- 4 Planned sale President and CEO sold 100 shares at $30.00 ($3,000)
- 4 Planned sale Chief Scientific Officer sold 9,215 shares at an average $30.04 ($276,776)
- 4 Planned sale President and CEO sold 9,536 shares at an average $30.13 ($287,316)
- 4 Open-market sale Chief Business Officer sold 10,000 shares at $30.03 ($300,300)
- 4 Planned sale CMO sold 25,000 shares at $27.63 ($690,658)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Scientific Officer sold 100,000 shares at $27.37 ($2,737,470)
- 4 Planned sale Chief Development Officer sold 29,709 shares at an average $29.69 ($881,915)
- 4 Exercise or conversion Chief Financial Officer acquired 70,000 shares (option exercise)
- 4 Open-market sale Chief Scientific Officer sold 75,000 shares at an average $28.27 ($2,120,101)
- 4 Open-market sale General Counsel sold 70,922 shares at an average $28.15 ($1,996,574)
- 4 Open-market sale CMO sold 7,162 shares at $28.29 ($202,603)
- 4 Open-market sale Chief Business Officer sold 42,068 shares at $29.03 ($1,221,133)
- 4 Open-market sale Chief Financial Officer sold 125,092 shares at an average $28.57 ($3,573,980)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 11 · 203 filings